Pasar al contenido principal

ESTUDIO DE LA EPOXIDO HIDROLASA SOLUBLE COMO NUEVA DIANA FARMACOLOGICA PARA LA ENFERMEDAD DE ALZHEIMER: MODULACION DE LAS VIAS DE INFLAMACION Y PROTEOLISIS.

SAF2016-77703-C2-2-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis de maestría (MasterThesis)

Neuroprotective mechanisms of resveratrol in a high-fat diet-fed Alzheimer's disease mouse model

  • Gatius, Alaó
Over the last decades there has been an over consumption of foods rich in animal fats that has led to a global obesity pandemic. Obesity presents itself with a number of comorbidities, including an increased risk for the development of neurodegenerative disorders such as Alzheimer’s disease (AD). On the other hand, reducing caloric intake has showed to delay age-related diseases and resveratrol, a polyphenol produced by a variety of plants, has emerged as a potent mimetic of this caloric restriction. The mechanisms underlying both effects are not fully understood and, as potential therapeutic targets, need to be thoroughly analyzed. To this end, we have analyzed molecular pathways involved in memory loss in mice as a result of a high-fat diet (HFD) administration and the role that resveratrol supplementation on this diet may play. We have focused on 6-months-old 5xFAD mice, which are transgenic AD mice with a high amyloid burden, and wild type (WT) mice. Both mice strains fed with HFD showed impairment of recognition memory but when resveratrol was added to the HFD, recognition memory was restored. Moreover, our results indicate that HFD boosts amyloid pathology in both, WT and 5xFAD mice, mainly through the potentiation of the amyloidogenic pathway and the reduction of the non-amyloidogenic one. Namely, we identified an increase in β-secretase (BACE1) protein levels in both strains and a decrease in α-secretase (ADAM10) expression in WT mice after HFD administration. Tau pathology was as well aggravated in both strains. Interestingly, HFD has showed the capacity to enhance the activity of the ubiquitin-proteasome system, being the most significant changes the induction of proteasome caspase-like and chymotrypsin-like activities. Remarkably, resveratrol has demonstrated the capability to normalize all the pathological changes induced by the HFD in both WT and 5xFAD mice, confirming its preventive and therapeutic potential against neurodegeneration., SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and the European Regional Development Fund (ERDF); AGAUR 2017-SGR-106 and the CERCA Programme of the Generalitat de Catalunya; R. Copas and C. Sanfeliu belong to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis de maestría (MasterThesis)

Lymphoblasts as potential peripheral biomarkers of Alzheimer's disease and the protective role of resveratrol

  • Senserrich, Júlia
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and first cause of dementia all over the world. It is characterized by a progressive neuronal loss. The main risk factor for developing AD is the age and it is known that there are shared pathological changes between them. Major pathological hallmarks include extracellular deposits of amyloid protein and intracellular deposits of neurofibrillary tau protein. Moreover, it is though that β-amyloid peptide induce cytotoxicity by the generation of reactive oxygen intermediates, contributing to protein tau’s hyperphosphorylation., The study used immortalised lymphocytes from patients of sporadic AD and age-matched healthy controls with following aims: First, use real-time PCR to verify the results of several genes expression analysed by array, in a previous study. Second, investigate the potential role of resveratrol, inducing an upregulation of genes involved in the antioxidant cell response and regulating the aging pathway. Finally, establish the different sensitivity between the human immortalized lymphocyte cell lines and human neuroblastoma cell lines, both treated with resveratrol and hydrogen peroxide (H2O2), an oxidative stress inductor., The current study was observed that gene expression results by PCR did not correlated with those obtained by array, suggesting a variability through individuals. Moreover, aging genes seemed to be more expressed by AD patients, but resveratrol did not induce any effect. Contrary to genes involved in an antioxidant response, which an upregulation induced by resveratrol was clearly demonstrated in most antioxidant genes tested. In addition, it was seen the high toxicity produced by an oxidative stress inductor and the trace that resveratrol 50µM could be the threshold of toxicity for neuronal cells, while lymphoblastomas showed to be more resistant to those compounds., SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and the European Regional Development Fund (ERDF); AGAUR 2017-SGR106 and the CERCA Programme of the Generalitat de Catalunya; C. Sanfeliu belong to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis de maestría (MasterThesis)

Epoxide Hydrolase enzyme as a therapeutic target against Alzheimer's Disease

  • Almenara-Fuentes, Lidia
Alzheimer’s Disease (AD) represents a serious problem for the population health due to the increase in the life expectancy. Inflammation in AD is widely present and it is considered as a contributor to the cognitive loss and neurodegeneration. Epoxyeicosatrienoic acids (EETs) have anti-inflammatory properties which disappear when the enzyme soluble Epoxide Hydrolase (sEH) metabolizes them to the corresponding dihydroxyeicosatrienoic acids (DHETs). SEH is emerging as a promising pharmacological target because allows the increase of EETs and keep them active. The aim of the present study was to calculate the half maximal inhibitory concentration (IC50) of a newly synthetized sEH inhibitors (UB21, UB23, UB24, UB28, EPB50 and EV52), study their toxicity and the anti-inflammatory effects. SH-SY5Y cell cultures were used to the IC50 calculation and the toxicity of each sEHi. To study the inflammatory effects, lipopolysaccharide (LPS) stimulated microglial, BV2 cells were used to obtain conditioned media with the proinflammatory mediators. Modulation of the inflammatory pathways iNOS and NFĸB, and the release of proinflammatory cytokines were analyzed by techniques of Western Blot, immunocytochemistry and ELISA. All agents showed a higher inhibitory potency than the reference compound 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), being the IC50 of UB23 and UB28 at nanomolar range. EV52 could not been tested due to their random activity values. All sEHi were not cytotoxic at the anticipated concentrations, except EV52. The preliminary testing of anti-inflammatory effects unveils UB23 as the best candidate, SAF2016-77703-C2-2-R of the Ministerio de Economía y Competitividad, Spain and the European Regional Development Fund (ERDF); AGAUR 2017-SGR-106 and the CERCA Programme of the Generalitat de Catalunya; R. Copas and C. Sanfeliu belong to Group 05 of CIBER Epidemiología y Salud Pública (CIBERESP) of the Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Spain., Peer reviewed